Literature DB >> 28008000

Stroke outcomes are worse with larger leukoaraiosis volumes.

Wi-Sun Ryu1, Sung-Ho Woo1, Dawid Schellingerhout2, Min Uk Jang3, Kyoung-Jong Park4, Keun-Sik Hong5, Sang-Wuk Jeong1, Jeong-Yong Na1, Ki-Hyun Cho6, Joon-Tae Kim6, Beom Joon Kim7, Moon-Ku Han7, Jun Lee8, Jae-Kwan Cha9, Dae-Hyun Kim9, Soo Joo Lee10, Youngchai Ko10, Yong-Jin Cho5, Byung-Chul Lee11, Kyung-Ho Yu11, Mi Sun Oh11, Jong-Moo Park12, Kyusik Kang12, Kyung Bok Lee13, Tai Hwan Park14, Juneyoung Lee15, Heung-Kook Choi16, Kiwon Lee17, Hee-Joon Bae18, Dong-Eog Kim19.   

Abstract

Leukoaraiosis or white matter hyperintensities are frequently observed on magnetic resonance imaging of stroke patients. We investigated how white matter hyperintensity volumes affect stroke outcomes, generally and by subtype. In total, 5035 acute ischaemic stroke patients were enrolled. Strokes were classified as large artery atherosclerosis, small vessel occlusion, or cardioembolism. White matter hyperintensity volumes were stratified into quintiles. Mean age (± standard deviation) was 66.3 ± 12.8, 59.6% male. Median (interquartile range) modified Rankin Scale score was 2 (1-3) at discharge and 1 (0-3) at 3 months; 16.5% experienced early neurological deterioration, and 3.3% recurrent stroke. The Cochran-Mantel-Haenszel test with adjustment for age, stroke severity, sex, and thrombolysis status showed that the distributions of 3-month modified Rankin Scale scores differed across white matter hyperintensity quintiles (P < 0.001). Multiple ordinal logistic regression analysis showed that higher white matter hyperintensity quintiles were independently associated with worse 3-month modified Rankin Scale scores; adjusted odds ratios (95% confidence interval) for the second to fifth quintiles versus the first quintile were 1.29 (1.10-1.52), 1.40 (1.18-1.66), 1.69 (1.42-2.02) and 2.03 (1.69-2.43), respectively. For large artery atherosclerosis (39.0%), outcomes varied by white matter hyperintensity volume (P = 0.01, Cochran-Mantel-Haenszel test), and the upper three white matter hyperintensity quintiles (versus the first quintile) had worse 3-month modified Rankin Scale scores; adjusted odds ratios were 1.45 (1.10-1.90), 1.86 (1.41-2.47), and 1.89 (1.41-2.54), respectively. Patients with large artery atherosclerosis were vulnerable to early neurological deterioration (19.4%), and the top two white matter hyperintensity quintiles were more vulnerable still: 23.5% and 22.3%. Moreover, higher white matter hyperintensities were associated with poor modified Rankin Scale improvement: adjusted odds ratios for the upper two quintiles versus the first quintile were 0.66 (0.47-0.94) and 0.62 (0.43-0.89), respectively. For small vessel occlusion (17.8%), outcomes tended to vary by white matter hyperintensitiy volume (P = 0.10, Cochran-Mantel-Haenszel test), and the highest quintile was associated with worse 3-month modified Rankin Scale scores: adjusted odds ratio for the fifth quintile versus first quintile, 1.98 (1.23-3.18). In this subtype, worse white matter hyperintensities were associated with worse National Institute of Health Stroke Scale scores at presentation. For cardioembolism (20.6%), outcomes did not vary significantly by white matter hyperintensity volume (P = 0.19, Cochran-Mantel-Haenszel test); however, the adjusted odds ratio for the highest versus lowest quintiles was 1.62 (1.09-2.40). Regardless of stroke subtype, white matter hyperintensities were not associated with stroke recurrence within 3 months of follow-up. In conclusion, white matter hyperintensity volume independently correlates with stroke outcomes in acute ischaemic stroke. There are some suggestions that stroke outcomes may be affected by leukoaraiosis differentially depending on stroke subtypes, to be confirmed in future investigations.
© The Author (2016). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  ischaemic stroke; magnetic resonance image; outcome; white matter hyperintensities

Mesh:

Year:  2016        PMID: 28008000      PMCID: PMC6276917          DOI: 10.1093/brain/aww259

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  47 in total

1.  tPA treatment for acute ischaemic stroke in patients with leukoaraiosis.

Authors:  M J H Ariës; M Uyttenboogaart; P C Vroomen; J De Keyser; G J Luijckx
Journal:  Eur J Neurol       Date:  2010-03-01       Impact factor: 6.089

2.  Thrombolysis is associated with consistent functional improvement across baseline stroke severity: a comparison of outcomes in patients from the Virtual International Stroke Trials Archive (VISTA).

Authors:  Nishant K Mishra; Patrick Lyden; James C Grotta; Kennedy R Lees
Journal:  Stroke       Date:  2010-10-14       Impact factor: 7.914

3.  Collateral flow and ischemic brain lesions in patients with unilateral carotid artery occlusion.

Authors:  R H C Bisschops; C J M Klijn; L J Kappelle; A C van Huffelen; J van der Grond
Journal:  Neurology       Date:  2003-05-13       Impact factor: 9.910

4.  MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging.

Authors:  F Fazekas; J B Chawluk; A Alavi; H I Hurtig; R A Zimmerman
Journal:  AJR Am J Roentgenol       Date:  1987-08       Impact factor: 3.959

5.  Greater stroke severity predominates over all other factors for the worse outcome of cardioembolic stroke.

Authors:  Keun-Sik Hong; Juneyoung Lee; Hee-Joon Bae; Ji Sung Lee; Dong-Wha Kang; Kyung-Ho Yu; Moon-Ku Han; Yong-Jin Cho; Pamela Song; Jong-Moo Park; Mi-Sun Oh; Jaseong Koo; Byung-Chul Lee
Journal:  J Stroke Cerebrovasc Dis       Date:  2013-05-19       Impact factor: 2.136

6.  NXY-059 for the treatment of acute ischemic stroke.

Authors:  Ashfaq Shuaib; Kennedy R Lees; Patrick Lyden; James Grotta; Antonio Davalos; Stephen M Davis; Hans-Christoph Diener; Tim Ashwood; Warren W Wasiewski; Ugochi Emeribe
Journal:  N Engl J Med       Date:  2007-08-09       Impact factor: 91.245

7.  Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.

Authors:  H P Adams; B H Bendixen; L J Kappelle; J Biller; B B Love; D L Gordon; E E Marsh
Journal:  Stroke       Date:  1993-01       Impact factor: 7.914

Review 8.  What are white matter hyperintensities made of? Relevance to vascular cognitive impairment.

Authors:  Joanna M Wardlaw; Maria C Valdés Hernández; Susana Muñoz-Maniega
Journal:  J Am Heart Assoc       Date:  2015-06-23       Impact factor: 5.501

Review 9.  Stroke statistics in Korea: part I. Epidemiology and risk factors: a report from the korean stroke society and clinical research center for stroke.

Authors:  Keun-Sik Hong; Oh Young Bang; Dong-Wha Kang; Kyung-Ho Yu; Hee-Joon Bae; Jin Soo Lee; Ji Hoe Heo; Sun U Kwon; Chang Wan Oh; Byung-Chul Lee; Jong S Kim; Byung-Woo Yoon
Journal:  J Stroke       Date:  2013-01-31       Impact factor: 6.967

10.  Longitudinal patterns of leukoaraiosis and brain atrophy in symptomatic small vessel disease.

Authors:  Christian Lambert; Philip Benjamin; Eva Zeestraten; Andrew J Lawrence; Thomas R Barrick; Hugh S Markus
Journal:  Brain       Date:  2016-03-01       Impact factor: 13.501

View more
  28 in total

1.  Impact of Cerebral Small Vessel Disease on Functional Recovery After Intracerebral Hemorrhage.

Authors:  Simone M Uniken Venema; Sandro Marini; Umme K Lena; Andrea Morotti; Michael Jessel; Charles J Moomaw; Christina Kourkoulis; Fernando D Testai; Steven J Kittner; H Bart Brouwers; Michael L James; Daniel Woo; Christopher D Anderson; Jonathan Rosand
Journal:  Stroke       Date:  2019-08-26       Impact factor: 7.914

2.  Mapping the Supratentorial Cerebral Arterial Territories Using 1160 Large Artery Infarcts.

Authors:  Dong-Eog Kim; Jong-Ho Park; Dawid Schellingerhout; Wi-Sun Ryu; Su-Kyoung Lee; Min Uk Jang; Sang-Wuk Jeong; Jeong-Yong Na; Jung E Park; Eun Ja Lee; Ki-Hyun Cho; Joon-Tae Kim; Beom Joon Kim; Moon-Ku Han; Jun Lee; Jae-Kwan Cha; Dae-Hyun Kim; Soo Joo Lee; Youngchai Ko; Byung-Chul Lee; Kyung-Ho Yu; Mi Sun Oh; Keun-Sik Hong; Yong-Jin Cho; Jong-Moo Park; Kyusik Kang; Tai Hwan Park; Kyung Bok Lee; Kyoung-Jong Park; Heung-Kook Choi; Juneyoung Lee; Hee-Joon Bae
Journal:  JAMA Neurol       Date:  2019-01-01       Impact factor: 18.302

Review 3.  Pathophysiological and clinical considerations in the perioperative care of patients with a previous ischaemic stroke: a multidisciplinary narrative review.

Authors:  Jatinder S Minhas; William Rook; Ronney B Panerai; Ryan L Hoiland; Phil N Ainslie; Jonathan P Thompson; Amit K Mistri; Thompson G Robinson
Journal:  Br J Anaesth       Date:  2019-12-06       Impact factor: 9.166

4.  White matter hyperintensity burden in patients with ischemic stroke treated with thrombectomy.

Authors:  Grégoire Boulouis; Nicolas Bricout; Wagih Benhassen; Marc Ferrigno; Guillaume Turc; Martin Bretzner; Joseph Benzakoun; Pierre Seners; Thomas Personnic; Laurence Legrand; Denis Trystram; Christine Rodriguez-Regent; Andreas Charidimou; Natalia S Rost; Serge Bracard; Charlotte Cordonnier; Catherine Oppenheim; Olivier Naggara; Hilde Henon
Journal:  Neurology       Date:  2019-09-13       Impact factor: 9.910

5.  Cognitive reserve impacts on disability and cognitive deficits in acute stroke.

Authors:  Roza M Umarova; Christoph Sperber; Christoph P Kaller; Charlotte S M Schmidt; Horst Urbach; Stefan Klöppel; Cornelius Weiller; Hans-Otto Karnath
Journal:  J Neurol       Date:  2019-06-28       Impact factor: 4.849

6.  Relation of Pre-Stroke Aspirin Use With Cerebral Infarct Volume and Functional Outcomes.

Authors:  Wi-Sun Ryu; Dawid Schellingerhout; Keun-Sik Hong; Sang-Wuk Jeong; Beom Joon Kim; Joon-Tae Kim; Kyung Bok Lee; Tai Hwan Park; Sang-Soon Park; Jong-Moo Park; Kyusik Kang; Yong-Jin Cho; Hong-Kyun Park; Byung-Chul Lee; Kyung-Ho Yu; Mi Sun Oh; Soo Joo Lee; Jae Guk Kim; Jae-Kwan Cha; Dae-Hyun Kim; Jun Lee; Moon-Ku Han; Man Seok Park; Kang-Ho Choi; Matthias Nahrendorf; Juneyoung Lee; Hee-Joon Bae; Dong-Eog Kim
Journal:  Ann Neurol       Date:  2021-10-05       Impact factor: 11.274

Review 7.  Cerebral Small Vessel Disease: Neuroimaging Features, Biochemical Markers, Influencing Factors, Pathological Mechanism and Treatment.

Authors:  Beida Ren; Ling Tan; Yuebo Song; Danxi Li; Bingjie Xue; Xinxing Lai; Ying Gao
Journal:  Front Neurol       Date:  2022-06-14       Impact factor: 4.086

8.  European Stroke Organisation (ESO) guidelines on intravenous thrombolysis for acute ischaemic stroke.

Authors:  Eivind Berge; William Whiteley; Heinrich Audebert; Gian Marco De Marchis; Ana Catarina Fonseca; Chiara Padiglioni; Natalia Pérez de la Ossa; Daniel Strbian; Georgios Tsivgoulis; Guillaume Turc
Journal:  Eur Stroke J       Date:  2021-02-19

9.  Severe Cerebral Small Vessel Disease Burden Is Associated With Poor Outcomes After Endovascular Thrombectomy in Acute Ischemic Stroke With Large Vessel Occlusion.

Authors:  Destiny Hooper; Tariq Nisar; David McCane; Jason Lee; Ken Chyuan Ling; Farhaan Vahidy; Kelvin Wong; Stephen Wong; David Chiu; Rajan Gadhia
Journal:  Cureus       Date:  2021-02-04

10.  Effects of Glycemic Gap on Post-Stroke Cognitive Impairment in Acute Ischemic Stroke Patients.

Authors:  Minwoo Lee; Jae-Sung Lim; Yerim Kim; Ju Hun Lee; Chul-Ho Kim; Sang-Hwa Lee; Min Uk Jang; Mi Sun Oh; Byung-Chul Lee; Kyung-Ho Yu
Journal:  Brain Sci       Date:  2021-05-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.